Gene and Molecular Pathways of Ozone Treatment Response in Gynecological Tumor Patients With Chronic Pelvic Pain Secondary to Cancer Treatment (OzoGynEpigen)
Gene and Molecular Pathway Characterization of the Response to Ozone Treatment in Gynecological Tumor Patients With Chronic Pelvic Pain Secondary to Radio-chemotherapy
Sponsor: Bernardino Clavo, MD, PhD
Listed as NCT06816095, this observational or N/A phase trial focuses on Chronic Pelvic Pain Syndrome (CPPS) and Gynecological Cancers and remains actively recruiting participants. Sponsored by Bernardino Clavo, MD, PhD, it has been updated 3 times since 2025, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
3 versions recorded-
Jun 2025 — Present [monthly]
Recruiting
-
Apr 2025 — Jun 2025 [monthly]
Recruiting
-
Mar 2025 — Apr 2025 [monthly]
Recruiting
First recorded
Feb 2025
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bernardino Clavo, MD, PhD
- Council of Gran Canaria
- Fundacion Canaria Instituto de Investigacion Sanitaria de Canarias
- Fundación DISA, Canary Islands, Spain
For direct contact, visit the study record on ClinicalTrials.gov .